Description : The Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert, categorically highlighting concerns about Meftal's active ingredient, mefenamic acid and Dicyclomine HCL, sold under the brand name 'Meftal-Spas'. According to the alert, the use of mefenamic acid in Meftal can lead to potential adverse reactions, causing DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms). Particularly women who have been taking the Meftal-Spas pill to alleviate period pain. Meftal-Spas is used for treating pain, fever, and spasms. Tehatta, West Bengal; India.